Nephrologic diseases Urological and Genital Diseases
Conditions
Interventions
Patients and Health care professional will be able to use eHealth system.
The trial has no formal patient inclusion. During the trial, patients will experience an improved IT-environm
Sponsors
Hannover Medical School
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All pediatric and adult nephrologic patients in the Region Hannover will be indirectly part of the trial by improving the IT-architecture.
Exclusion criteria
Exclusion criteria: N/A
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Implementation of a cross-sector electronic case file eFA including teleconsultations and patient access. Indicator: 50% of patients with shared use of eFA after 30 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Evaluation of care provider needs on data and information sharing, acceptance and feasibility (qualitatively, interviews with GPs / pediatricians) at 30 months. 2. Implementation of a decision support system for GFR deterioration and cardiovascular comorbidities. Indicator: System is implemented at 30 months 3. Comparison of intersectoral treatment quality between Hannover Region and Erlangen. Indicator: Analysis performed at 30 months 4. Reduction of complications of nephrological diseases. Indicator: Reduction of complications requiring inpatient treatment. Indicator: A 10% reduction of hospital expenditure within 30 months compared to a control cohort (historical control patients who did not participate in the program) 5. Reduction in cardiovascular events. Indicator: The number of hospitalizations due to cardiovascular events will be reduced > 10% within 30 months. 6. After the establishment of NEPHRO-DIGITAL, participant quality of life will improve significantly. Indicator: In the mental subscale of the SF-12, 80% of the participating patients will reach values which do not differ from population norm data within 30 months. 7. Is the use of the new digital elements and the quality of life gender-dependent? Does a migration background play a role in the acceptance of digital medicine? Indicator: Participation rate in subgroups is not significantly different after 30 months. | — |
Countries
Germany
Outcome results
None listed